Ancrod Stroke Study

Completed

Phase 3 Results

Results

There was no significant difference in overall mean scores on the Scandinavian Stroke Scale. Those patients with ancrod-induced 6-hour fibrinogen levels 130 mg/dL or less had a marginally significantly better neurological outcome on the Scandinavian Stroke Scale, mortality, and Barthel Index than ancrod-treated patients with higher fibrinogen levels.